82 Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor RWJ-270201 : S. Bantia1, S. Ananth1, L. Horn1, C. Parker1, U. Gulati2, P. Chand1, Y. Babu1, G. Air2 1BioCryst Pharmaceuticals, Inc., Birmingham, AL, U.S.A., 2University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73190
- 30 April 2000
- journal article
- abstracts
- Published by Elsevier in Antiviral Research
- Vol. 46 (1) , A60
- https://doi.org/10.1016/s0166-3542(00)90413-3